<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Martino F</submitter><funding>Associazione Italiana per la Ricerca sul Cancro</funding><funding>Ministero della Salute</funding><funding>Ministero della Salute Ricerca Corrente: 2024-2025</funding><funding>European Research Council</funding><funding>Italian Ministry of University and Scientific Research grant PRIN 2020</funding><funding>FPRC 5xmille Ministero Salute 2020</funding><funding>Fondazione Piemontese per la Ricerca sul Cancro, FPRC 5xmille Ministero Salute 2017 PTCRC-INTRA 2020</funding><pagination>e02269</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12631847</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(43)</volume><pubmed_abstract>TBC1D22B is a GTPase-activating protein (GAP) associated with poor prognosis in breast cancer (BC). Using complementary proximity-labeling and co-immunoprecipitation proteomics, the TBC1D22B interactome in BC cells is defined, revealing strong enrichment in components of the ER-to-Golgi trafficking machinery, endosomal transport, and adhesion-related pathways. Functional assays, using the Retention Using Selective Hooks (RUSH) system, demonstrate that TBC1D22B inhibits ER-to-Golgi transport in a GAP-dependent manner. Mechanistic studies identify RAB1B as a direct target of TBC1D22B, and RAB1B silencing phenocopies the trafficking defects caused by TBC1D22B overexpression. In 3D culture, TBC1D22B promotes spheroid growth in a manner dependent on its GAP activity and not replicated by its pa</pubmed_abstract><journal>Advanced science (Weinheim, Baden-Wurttemberg, Germany)</journal><pubmed_title>TBC1D22B Regulates ER-to-Golgi Trafficking via RAB1B Inactivation and Promotes Oncogenic Programs in Breast Cancer.</pubmed_title><pmcid>PMC12631847</pmcid><funding_grant_id>22811</funding_grant_id><funding_grant_id>PRO-ACTIVE</funding_grant_id><funding_grant_id>PNRR-MCNT2-2023-12378490 Next Generation EU</funding_grant_id><funding_grant_id>2020R2BP2E</funding_grant_id><funding_grant_id>ERC-CoG2020 101002280</funding_grant_id><funding_grant_id>2022W93FTW</funding_grant_id><funding_grant_id>projectSEE-HER</funding_grant_id><funding_grant_id>101002280</funding_grant_id><funding_grant_id>24415</funding_grant_id><pubmed_authors>Martino F</pubmed_authors><pubmed_authors>Freddi S</pubmed_authors><pubmed_authors>Murabito A</pubmed_authors><pubmed_authors>Pennisi R</pubmed_authors><pubmed_authors>Bussolino F</pubmed_authors><pubmed_authors>Bedin F</pubmed_authors><pubmed_authors>Matoskova B</pubmed_authors><pubmed_authors>Boncompain G</pubmed_authors><pubmed_authors>Sigismund S</pubmed_authors><pubmed_authors>Lanzetti L</pubmed_authors><pubmed_authors>Cuomo A</pubmed_authors><pubmed_authors>Lupi M</pubmed_authors><pubmed_authors>Fontana S</pubmed_authors><pubmed_authors>Fardin A</pubmed_authors><pubmed_authors>Perez F</pubmed_authors><pubmed_authors>Villari G</pubmed_authors><pubmed_authors>Andreoli L</pubmed_authors></additional><is_claimable>false</is_claimable><name>TBC1D22B Regulates ER-to-Golgi Trafficking via RAB1B Inactivation and Promotes Oncogenic Programs in Breast Cancer.</name><description>TBC1D22B is a GTPase-activating protein (GAP) associated with poor prognosis in breast cancer (BC). Using complementary proximity-labeling and co-immunoprecipitation proteomics, the TBC1D22B interactome in BC cells is defined, revealing strong enrichment in components of the ER-to-Golgi trafficking machinery, endosomal transport, and adhesion-related pathways. Functional assays, using the Retention Using Selective Hooks (RUSH) system, demonstrate that TBC1D22B inhibits ER-to-Golgi transport in a GAP-dependent manner. Mechanistic studies identify RAB1B as a direct target of TBC1D22B, and RAB1B silencing phenocopies the trafficking defects caused by TBC1D22B overexpression. In 3D culture, TBC1D22B promotes spheroid growth in a manner dependent on its GAP activity and not replicated by its pa</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-05T17:21:29.812Z</modification><creation>2026-05-19T03:11:57.39Z</creation></dates><accession>S-EPMC12631847</accession><cross_references><pubmed>40878439</pubmed><doi>10.1002/advs.202502269</doi></cross_references></HashMap>